Linked Life Data

19424045

Source:http://linkedlifedata.com/resource/pubmed/id/19424045

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2009-5-8
pubmed:abstractText
Cure of the metabolic defect in primary hyperoxaluria type 1 (PH1) is possible with liver transplantation (LTx). Preemptive LTx (PLTx) was promoted to prevent chronic kidney disease due to nephrocalcinosis and urolithiasis. However, timing of this procedure is difficult in view of the heterogeneity of PH1 and effective conservative treatment. Combined liver-kidney transplantation (LKTx) is able to cure metabolic defect and replace renal function at the same time and is effective and indicated for patients with or approaching end-stage renal disease (ESRD). Sometimes a sequential approach for LKTx (first liver, then kidney) has been recommended.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1534-6080
pubmed:author
pubmed:issnType
Electronic
pubmed:day
15
pubmed:volume
87
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1415-21
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Transplantation procedures in children with primary hyperoxaluria type 1: outcome and longitudinal growth.
pubmed:affiliation
Department of Pediatrics, Pediatric Gastroenterology and Hepatology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany. f.brinkert@uke.de
pubmed:publicationType
Journal Article